SG11201508032RA - (sugar chain)-polypeptide complex - Google Patents

(sugar chain)-polypeptide complex

Info

Publication number
SG11201508032RA
SG11201508032RA SG11201508032RA SG11201508032RA SG11201508032RA SG 11201508032R A SG11201508032R A SG 11201508032RA SG 11201508032R A SG11201508032R A SG 11201508032RA SG 11201508032R A SG11201508032R A SG 11201508032RA SG 11201508032R A SG11201508032R A SG 11201508032RA
Authority
SG
Singapore
Prior art keywords
sugar chain
polypeptide complex
polypeptide
complex
sugar
Prior art date
Application number
SG11201508032RA
Inventor
Hayato Saijo
Hirofumi Ochiai
Keisuke Tazuru
Taiji Shimoda
Original Assignee
Glytech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glytech Inc filed Critical Glytech Inc
Publication of SG11201508032RA publication Critical patent/SG11201508032RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/009Materials resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06Use of macromolecular materials
    • A61L33/12Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding
SG11201508032RA 2013-03-30 2014-03-21 (sugar chain)-polypeptide complex SG11201508032RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013075493 2013-03-30
PCT/JP2014/057927 WO2014162906A1 (en) 2013-03-30 2014-03-21 (sugar chain)-polypeptide complex

Publications (1)

Publication Number Publication Date
SG11201508032RA true SG11201508032RA (en) 2015-10-29

Family

ID=51658205

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508032RA SG11201508032RA (en) 2013-03-30 2014-03-21 (sugar chain)-polypeptide complex

Country Status (16)

Country Link
US (1) US9981059B2 (en)
EP (1) EP2980098B1 (en)
JP (1) JP6460978B2 (en)
KR (1) KR102186698B1 (en)
CN (1) CN105408346B (en)
AU (1) AU2014247614B2 (en)
BR (1) BR112015024502A2 (en)
CA (1) CA2908136C (en)
DK (1) DK2980098T3 (en)
ES (1) ES2703979T3 (en)
MY (1) MY169123A (en)
PH (1) PH12015502235A1 (en)
RU (1) RU2664539C2 (en)
SG (1) SG11201508032RA (en)
TW (1) TWI639617B (en)
WO (1) WO2014162906A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2987863A4 (en) * 2013-04-19 2017-04-19 Glytech, Inc. Method for producing activated sugar-chain derivative, and activated sugar-chain derivative
CA2943734A1 (en) * 2014-03-28 2015-10-01 Otsuka Chemical Co., Ltd. Hemostatic pharmaceutical composition
PL3436012T3 (en) 2016-03-30 2024-04-08 Convatec Technologies Inc. Modified wound dressings
CN107529533B (en) * 2017-09-07 2020-10-30 中国药科大学 PH-sensitive polypeptide capable of self-assembling into hydrogel and application thereof as drug loading material
CN108553683B (en) * 2018-05-21 2021-06-01 中国石油大学(华东) Composite nano hemostatic material based on natural polysaccharide/short peptide and preparation method thereof
JP7142286B2 (en) * 2018-07-13 2022-09-27 慶應義塾 Sugar chain-polypeptide complex containing selenium-containing amino acid, and pharmaceutical use thereof
KR102248381B1 (en) 2020-11-26 2021-05-06 박시형 bell tester

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
EP1405858B1 (en) 2001-06-19 2013-01-02 Glytech, Inc. Process for producing sugar chain asparagine derivative
US7943763B2 (en) 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
TWI335920B (en) 2002-12-24 2011-01-11 Yasuhiro Kajihara Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof
CA2511655C (en) 2002-12-26 2009-07-07 Otsuka Chemical Co., Ltd. Three-branched sugar-chain asparagine derivatives, the sugar-chain asparagines, the sugar chains, and processes for producing these
TR201820053T4 (en) 2003-02-04 2019-01-21 Glytech Inc Process for producing sugar chain asparagine derivative.
SG144945A1 (en) 2003-07-28 2008-08-28 Otsuka Chemical Co Ltd Aminated complex-type sugar chain derivatives and process for the production thereof
US8299032B2 (en) 2005-06-27 2012-10-30 Menicon Co., Ltd. Self-assembling peptide and gel produced from the same
TWI342880B (en) 2005-07-19 2011-06-01 Otsuka Chemical Co Ltd Method for producing sugar chain derivatives, and sugar chain derivatives
JP2007217376A (en) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology Self-assembly peptide composition
US9415084B2 (en) 2007-03-14 2016-08-16 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP2012082180A (en) * 2010-10-14 2012-04-26 Nagoya Univ Self-organizing peptide hydrogel for bone regeneration
US20140045951A1 (en) 2011-04-27 2014-02-13 Osaka University Synthetic vitreous material

Also Published As

Publication number Publication date
AU2014247614B2 (en) 2017-09-21
CA2908136A1 (en) 2014-10-09
PH12015502235B1 (en) 2016-02-01
TWI639617B (en) 2018-11-01
KR20160002835A (en) 2016-01-08
US20160129150A1 (en) 2016-05-12
EP2980098B1 (en) 2018-10-03
EP2980098A4 (en) 2016-11-09
TW201533061A (en) 2015-09-01
BR112015024502A2 (en) 2017-07-18
RU2015146739A (en) 2017-05-05
US9981059B2 (en) 2018-05-29
WO2014162906A1 (en) 2014-10-09
JP6460978B2 (en) 2019-01-30
CN105408346B (en) 2019-05-03
KR102186698B1 (en) 2020-12-07
MY169123A (en) 2019-02-18
RU2664539C2 (en) 2018-08-20
JPWO2014162906A1 (en) 2017-02-16
CA2908136C (en) 2021-06-29
AU2014247614A1 (en) 2015-09-24
DK2980098T3 (en) 2019-01-28
PH12015502235A1 (en) 2016-02-01
CN105408346A (en) 2016-03-16
EP2980098A1 (en) 2016-02-03
ES2703979T3 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
HK1219427A1 (en) Complex
AU350395S (en) Necklace
AU353527S (en) Earring
SG11201508032RA (en) (sugar chain)-polypeptide complex
HUE039509T2 (en) Camshaft
HK1215062A1 (en) Chain
ZA201508974B (en) Conveyor chain
HK1200914A1 (en) Glucose meter
IL230195A0 (en) Spacing mechanism
AU348413S (en) Chocolate
GB2521489B (en) Bracelet
SG2013065297A (en) Chain structure
AU353922S (en) Confectionery
AU353915S (en) Confectionery
AU353917S (en) Confectionery
AU353919S (en) Confectionery
AU353910S (en) Confectionery
AU353920S (en) Confectionery
AU353921S (en) Confectionery
AU353914S (en) Confectionery
AU353913S (en) Confectionery
AU353912S (en) Confectionery
AU353911S (en) Confectionery
AU353918S (en) Confectionery
AU352773S (en) Confectionery